The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Support side: New 13D filer — insiders or holders bought while this setup is live; see the timeline.
Radar 82 (high attention) · dilution pressure high · listing risk low · governance risk elevated · runway cash-flow positive · strongest signal: Offering (424B) (Aug 10, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going-concern language, going concern in 8-k, negative equity) coexists with live selling machinery (atm program, shelf filed, offering (424b)). Base case is a discounted raise; the question is when, not if.
An activist has arrived at a company that needs cash — a potential catalyst, but any financing terms may favour the newcomer. A new active >5% holder appeared while the company is under cash or listing pressure - the classic precursor to a recapitalization, board change, or takeover at a discount.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Aug 14, 2026 | ▲ New 13D filer | Schedule 13D filed 2026-08-14 filing | 45 |
| Aug 13, 2026 | · Form 4 burst | 6 Form 4 filings in 30 days filing | 15 |
| Aug 10, 2026 | ▼ Offering (424B) | 424B5 prospectus supplement 2026-08-10; 0 prior 424B filings in 12m filing | 50 |
| Aug 10, 2026 | ▼ Shelf filed | S-3 filed 2026-08-10 filing | 39 |
| Aug 10, 2026 | ▼ ATM program | “atm” language in 8-K (EX-5.1) filed 2026-08-10 filing | 38 |
| Aug 10, 2026 | ▼ ATM program | “atm” language in 424B5 (424B5) filed 2026-08-10 filing | 38 |
| Aug 10, 2026 | ▼ ATM program | “atm” language in S-3 (S-3) filed 2026-08-10 filing | 34 |
| Aug 10, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-1.2) filed 2026-08-10 filing | 32 |
| Aug 6, 2026 | ▼ Going-concern language | “going concern periodic” language in 10-Q (10-Q) filed 2026-08-06 filing | 37 |
| Aug 6, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (EX-99.2) filed 2026-08-06 filing | 31 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-243,200,000 as of 2026-06-30 filing | 31 |
VIVS VivoSim Labs, INC. · HCWB HCW Biologics Inc. · CYCU Cycurion, Inc. · BIAF bioAffinity Technologies, In · XHLD TEN Holdings, Inc. · VSEE VSEE HEALTH, INC. · screener →